Osakidetza ha elevado a 13 los casos de pérdida de visión en pacientes operados en hospitales de Euskadi. Según ha informado el Servicio Vasco de Salud a través de una nota, el número de casos declarados en Pais Vasco es "a día de hoy de 13": ocho en el Hospital Universitario de Donostia, uno en el Hospital Universitario de Cruces y cuatro más en un centro sanitario privado.
Grifols apuesta por Irlanda para instalar su cerebro gestor. Coincidiendo con la inauguración oficial este jueves de su nueva planta logística de distribución mundial en Dublín, la cotizada en el Ibex 35 ha decidido trasladar a la isla la toma de decisiones sobre política comercial, I+D, nuevos productos y cadena de suministro de su principal negocio. Esta división de biociencia, especializada en tratamientos con proteínas plasmáticas, supuso el 76,7% de los 1.900 millones de facturación en el primer semestre de año.
La posible apertura de un nuevo gran hospital privado en la denominada quinta torre del Paseo de la Castellana, puede poner a Madrid en el centro del turismo sanitario, nacional e internacional. Este proyecto se suma al gran centro que la Clínica Universitaria de Navarra ya construye en la capital y se une a los planes de expansión de otros grupos como Quirón Salud y HM Hospitales de Madrid. ¿Se puede convertir Madrid en el Houston europeo? ¿Será un lugar donde pacientes de todo el mundo viajen para curarse como en la ciudad texana?
Eye-tracking devices might help some patients communicate even when mechanical ventilators make it impossible for them to speak, a small pilot project suggests.
Researchers offered eye-trackers to 12 patients on ventilators in intensive care units (ICUs) at the Johns Hopkins Hospital in Baltimore, Maryland, during 2013 and 2014. All of the participants were cognitively capable of communication and able to convey comprehension by blinking, nodding their head or some other motion.
Bionic hands startup Open Bionics now makes Iron Man and Elsa-themed hands and arms for the smallest of amputees – kids.
Open Bionics hopes to get kids excited about their prosthetics with designs from Marvel, Frozen and Star Wars.
“[Kids] won’t have to do boring physical therapy, they’ll train to become heroes,” reads the Open Bionics website about the announcement. “They’re not just getting medical devices, they’re getting bionic hands inspired by their favorite characters.”
Donald Ingber is known as a pioneer in the organ-on-a-chip field. But the founding director of Harvard University’s Wyss Institute apparently has some other ideas up his sleeve—like a method of clearing dangerous infections from the blood, a technology that has formed the basis for his latest startup.
Procyrion, a Houston biotech developing a device to treat chronic heart failure, has raised $10 million.
The company has built a circulatory support pump named the Aortix that essentially serves as a crutch for the heart, aiding the organ to push more blood through the circulatory system and to vital organs. The device, which is thinner than a pencil, can be implanted in the aorta of heart failure patients via a catheter threaded through the femoral artery.
A Seattle biotech and the University of Texas M.D. Anderson Cancer Center announced the formation of a new company seeking to find personalized antibodies that help fight cancer.
NContact, a medical device company focused on treatments for heart rhythm disorders, is set to be acquired by AtriCure in a cash and stock deal valued at $99 million.
